Kiniksa Pharmaceuticals International, plc
KNSA
$20.25
-$1.51-6.94%
| Weiss Ratings | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C- | |||
| Rating Factors | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.09 | |||
| Price History | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.03% | |||
| 30-Day Total Return | 1.15% | |||
| 60-Day Total Return | 1.25% | |||
| 90-Day Total Return | -3.98% | |||
| Year to Date Total Return | 1.55% | |||
| 1-Year Total Return | 12.13% | |||
| 2-Year Total Return | 91.94% | |||
| 3-Year Total Return | 85.61% | |||
| 5-Year Total Return | 13.83% | |||
| 52-Week High % Change | -22.70% | |||
| 52-Week Low % Change | 31.40% | |||
| Price | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $28.15 | |||
| 52-Week Low Price | $16.56 | |||
| 52-Week Low Price (Date) | Apr 19, 2024 | |||
| 52-Week High Price (Date) | Oct 28, 2024 | |||
| Valuation | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.58B | |||
| Enterprise Value | 1.35B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.61 | |||
| Earnings Per Share Growth | -424.39% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.72 | |||
| Price/Book (Q) | 3.60 | |||
| Enterprise Value/Revenue (TTM) | 3.18 | |||
| Price | $20.25 | |||
| Enterprise Value/EBITDA (TTM) | -30.67 | |||
| Enterprise Value/EBIT | -29.53 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 72.32M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 431 9100 | |||
| Address | -- | |||
| Website | www.kiniksa.com | |||
| Country | United Kingdom | |||
| Year Founded | 2015 | |||
| Profitability | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -10.77% | |||
| Profit Margin | -10.20% | |||
| Management Effectiveness | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -5.15% | |||
| Return on Equity | -- | |||
| Income Statement | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 423.24M | |||
| Total Revenue (TTM) | 423.24M | |||
| Revenue Per Share | $5.85 | |||
| Gross Profit (TTM) | 234.02M | |||
| EBITDA (TTM) | -43.92M | |||
| EBIT (TTM) | -45.62M | |||
| Net Income (TTM) | -43.19M | |||
| Net Income Avl. to Common (TTM) | -43.19M | |||
| Total Revenue Growth (Q YOY) | 46.93% | |||
| Earnings Growth (Q YOY) | -135.22% | |||
| EPS Diluted (TTM) | -0.61 | |||
| EPS Diluted Growth (Q YOY) | -134.96% | |||
| Balance Sheet | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 243.63M | |||
| Cash Per Share (Q) | $3.37 | |||
| Total Current Assets (Q) | 331.80M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 438.44M | |||
| Current Ratio (Q) | 3.298 | |||
| Book Value Per Share (Q) | $6.05 | |||
| Total Assets (Q) | 580.55M | |||
| Total Current Liabilities (Q) | 100.62M | |||
| Total Debt (Q) | 9.86M | |||
| Total Liabilities (Q) | 142.12M | |||
| Total Common Equity (Q) | 438.44M | |||
| Cash Flow | KNSA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 37.67M | |||
| Cash from Financing (TTM) | 12.27M | |||
| Net Change in Cash (TTM) | 75.63M | |||
| Levered Free Cash Flow (TTM) | 22.57M | |||
| Cash from Operations (TTM) | 25.69M | |||
